Pharma Equity Group A/S earnings
Annual earnings per share (DKK per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2025 | 2025-12-31 | DKK -2.00 | DKK -2.00 | 2026-06-19T05:51:49Z |
| 2024 | 2024-12-31 | DKK -2.00 | DKK -2.00 | 2026-06-19T05:51:49Z |
Revenue & profit (DKK)
| Concept | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 0 | DKK 0 |
| Profit for the year | -DKK 25.4M | -DKK 40.6M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in Pharma Equity Group A/S's ESEF annual reports (source:
filings.xbrl.org).
Figures are in DKK, as reported. Not investment advice.